Is Now The Time To Put Clinuvel Pharmaceuticals (ASX:CUV) On Your Watchlist?
May 09
Australian (ASX) Biotech Industry Analysis
UpdatedMay 30, 2023
DataAggregated Company Financials
Companies40
- 7D0.09%
- 3M4.2%
- 1Y12.1%
- YTD9.2%
The Biotech industry has been flat over the last week, but Telix Pharmaceuticals has lost 3.2%. The past year has been better, since the industry has gained 12% in that time. As for the next few years, earnings are expected to grow by 20% per annum.
Industry Valuation and Performance
Has the Australian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 May 2023 | AU$157.4b | AU$18.4b | AU$2.4b | 40.4x | 66x | 8.6x |
| Thu, 27 Apr 2023 | AU$156.3b | AU$18.2b | AU$2.3b | 41.8x | 66.6x | 8.6x |
| Sat, 25 Mar 2023 | AU$146.9b | AU$18.1b | AU$2.3b | 39.3x | 62.7x | 8.1x |
| Mon, 20 Feb 2023 | AU$151.9b | AU$17.3b | AU$2.3b | 51.3x | 66.5x | 8.8x |
| Wed, 18 Jan 2023 | AU$148.4b | AU$15.5b | AU$2.5b | 52.2x | 60.5x | 9.6x |
| Fri, 16 Dec 2022 | AU$151.7b | AU$15.9b | AU$2.5b | 46.9x | 59.9x | 9.5x |
| Sun, 13 Nov 2022 | AU$149.4b | AU$16.1b | AU$2.6b | 45.4x | 58.5x | 9.3x |
| Tue, 11 Oct 2022 | AU$144.3b | AU$16.8b | AU$2.7b | 40.7x | 53.4x | 8.6x |
| Thu, 08 Sep 2022 | AU$149.5b | AU$15.8b | AU$2.5b | 44.6x | 59.4x | 9.5x |
| Sat, 06 Aug 2022 | AU$151.3b | AU$15.5b | AU$2.8b | 41.6x | 54.2x | 9.8x |
| Mon, 04 Jul 2022 | AU$135.9b | AU$15.9b | AU$2.9b | 34.5x | 47.3x | 8.6x |
| Wed, 01 Jun 2022 | AU$137.8b | AU$15.0b | AU$2.7b | 36.5x | 51.2x | 9.2x |
| Fri, 29 Apr 2022 | AU$136.3b | AU$15.1b | AU$2.8b | 36.3x | 49.4x | 9x |
| Sun, 27 Mar 2022 | AU$135.1b | AU$14.3b | AU$2.6b | 39.4x | 52.1x | 9.4x |
| Tue, 22 Feb 2022 | AU$136.0b | AU$15.0b | AU$2.7b | 39.2x | 50.2x | 9.1x |
| Thu, 20 Jan 2022 | AU$140.5b | AU$14.6b | AU$2.8b | 39.2x | 50.6x | 9.6x |
| Sat, 18 Dec 2021 | AU$142.1b | AU$14.6b | AU$2.8b | 39.5x | 51.3x | 9.8x |
| Mon, 15 Nov 2021 | AU$153.3b | AU$14.3b | AU$2.7b | 43.2x | 56.7x | 10.7x |
| Wed, 13 Oct 2021 | AU$145.1b | AU$14.2b | AU$2.7b | 41.4x | 54.1x | 10.2x |
| Fri, 10 Sep 2021 | AU$150.1b | AU$14.0b | AU$2.6b | 43.5x | 57.2x | 10.7x |
| Sun, 08 Aug 2021 | AU$146.2b | AU$14.0b | AU$2.6b | 42.8x | 55.7x | 10.5x |
| Sat, 01 May 2021 | AU$132.5b | AU$13.5b | AU$2.8b | 37.3x | 46.8x | 9.8x |
| Tue, 02 Feb 2021 | AU$132.3b | AU$13.1b | AU$3.0b | 35.8x | 44.2x | 10.1x |
| Fri, 06 Nov 2020 | AU$138.5b | AU$13.5b | AU$2.9b | 31.2x | 48.1x | 10.2x |
| Mon, 10 Aug 2020 | AU$130.3b | AU$13.5b | AU$2.7b | 40.3x | 48.9x | 9.7x |
Price to Earnings Ratio
44.6x
Current Industry PE
- Investors are optimistic on the Australian Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 66.0x which is higher than its 3-year average PE of 53.0x.
- The 3-year average PS ratio of 9.7x is higher than the industry's current PS ratio of 8.6x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 7.1% per year over the last three years.
- Meanwhile revenues for these companies have grown 7.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Australian Biotech compare with similar industries?
| AU Market | -0.72% | |
| Healthcare | -0.40% | |
| Biotech | 0.088% | |
| Biotech | 0.088% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARX Aroa Biosurgery | AU$1.00 | 8.7% +AU$27.4m | 27.4% | PS7.2x | |
| PAB Patrys | AU$0.012 | 20.0% +AU$4.1m | -46.7% | PS7x | |
| CYP Cynata Therapeutics | AU$0.14 | 11.5% +AU$2.7m | -63.7% | PS10x | |
| NSB NeuroScientific Biopharmaceuticals | AU$0.11 | 11.1% +AU$1.6m | -54.2% | PS13.6x | |
| TRP Tissue Repair | AU$0.28 | 10.0% +AU$1.5m | -1.8% | PS96.7x |
